Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2013

VistaGen Therapeutics, Inc. (VSTA) Turns Back Time to Give Once-Promising Drug Candidates a Second Chance

Posted on November 14, 2013 by MissionIR

VistaGen Therapeutics, a biotechnology company, is blazing new trails by looking to the past. The company has developed a pioneering stem cell technology platform that can give a second chance to potentially lifesaving drugs that have been shelved during human … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

CAMAC Energy Inc. (CAK) Offshore Nigeria Oyo Field Potential Improves, Hydrocarbons Now Confirmed in Miocene Formation, Also Q3 Data

Posted on November 13, 2013 by MissionIR

CAMAC Energy, who is focused on oil and gas E&P in Africa via their positions in The Gambia, Kenya, and in Nigeria via interest (30% WI) in a production sharing contract in the Oyo Oilfield, some 75 miles off the … Continue reading →

Posted in Small Cap News | Leave a comment

Ocean Power Technologies, Inc. (OPTT) is “One to Watch”

Posted on November 13, 2013 by MissionIR

Ocean Power Technologies has developed what is arguably the most impressive utility-scale wave energy harvesting system on the market today, the PowerBuoy®, as an array deployable solution for producing hundreds of megawatts of endless clean energy directly from a given … Continue reading →

Posted in Ones to Watch, Small Cap News | Leave a comment

Chanticleer Holdings, Inc. (HOTR) Closes $800,000 Private Placement with Accredited Investors

Posted on November 13, 2013 by MissionIR

Today before the opening bell, Chanticleer Holdings announced the closing of a private offering. Pursuant to the Subscription Agreement entered with three accredited investors, the Company sold an aggregate of 160,000 Units at a purchase price of $5.00 per Unit, … Continue reading →

Posted in Chanticleer Holdings Inc. HOTR | Leave a comment

Versar, Inc. (VSR) Receives $8.8 Million in Subcontract Extensions to Support DOD’s Reconstruction Efforts in Afghanistan

Posted on November 13, 2013 by MissionIR

Versar announced it has been awarded $8.8 million in subcontract extensions from HDR Environmental, Operations & Construction, Inc. to support continued construction management and quality assurance operations in Afghanistan. Supporting the Air Force’s construction responsibilities, the operations will take place … Continue reading →

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Strategic Business Model Employs Diverse Product Lineup

Posted on November 12, 2013 by MissionIR

Cardium Therapeutics is a health sciences and regenerative medicine company strategizing to acquire and develop new and innovative bio-medical product opportunities that have definable pathways to commercialization, partnering, sale, or other economic monetizations. To avoid the risk of relying on … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Money-on-Mobile, a Subsidiary of Calpian, Inc. (CLPI), Receives Two Prestigious Awards

Posted on November 12, 2013 by MissionIR

Money-on-Mobile, a subsidiary of Calpian, Inc., was recently honored with two prestigious and highly competitive awards for its outstanding contributions in the area of mobile-based financial services. Founded in 2012, Money-on-Mobile is the largest mobile payments company in India. The … Continue reading →

Posted in Calpian Inc. CLPI | Leave a comment

Lincoln Educational Services Corp. (LINC) Honors U.S. Veterans through American Hero Scholarship Program

Posted on November 12, 2013 by MissionIR

Lincoln Educational Services, a national leader in specialized technical training and supporter of students turning their passions into professional success, announced a scholarship opportunity specifically for veterans, as well as other service members of America’s Armed Forces. The American Hero … Continue reading →

Posted in Small Cap News | Leave a comment

Horizon Pharma, Inc. (HZNP) Inks Exclusive Agreement with Mundipharma to Commercialize LODOTRA in Middle East and Africa Regions

Posted on November 12, 2013 by MissionIR

Specialty pharmaceutical company Horizon Pharma announced that its Swiss subsidiary has signed an exclusive agreement with Mundipharma to commercialize and distribute LODOTRA in the Middle East and African regions. LODOTRA is an innovative delayed-release formulation of prednisone that is designed … Continue reading →

Posted in Small Cap News | Leave a comment

Boston Therapeutics, Inc. (BTHE) Begins Enrolling Patients in Phase 2b Trial for PAZ320

Posted on November 12, 2013 by MissionIR

Boston Therapeutics announced it has begun enrolling patients in a Phase 2b Trial for its PAZ320 drug today. A total of 24 patients with type 2 diabetes currently being treated with metformin will be administered PAZ320 under double-blind, placebo-controlled conditions. … Continue reading →

Posted in Boston Therapeutics Inc. BTHE | Leave a comment